|
Focus on Innovation:
Preservon® Technology Preserves Time and Quality
 Life Net Health’s PRESERVON® Technology is a radical innovation in allograft bio-implant preservation. Preservon® is a proprietary and patented glycerol-based preservation technology that allows allograft bio-implants to be stored in a fully hydrated state at ambient temperature. This eliminates the need to freeze or freeze-dry allograft bio-implants, doing away with lengthy thawing or rehydration times.
Testing conducted both by LifeNet Health and independent sources, including biomechanical, biocompatibility and osteoconductivity analyses, have found the safety and performance of Preservon®-treated and frozen or freeze-dried preserved allograft bio-implants to be comparable.
Glycerol, the active ingredient in Preservon®, acts as a humectant, maintaining the moisture within the allograft, while providing a bacteriostatic environment. These properties allow ambient temperature storage of the allograft without degradation.
Preservon® is more efficient and convenient than conventional preservation models allow. Frozen or free-dried allografts can require up to 60 minutes to thaw or rehydrate, compared to Preservon®-treated bio-implants, which only require a minimal rinse and do not require hydration.
LifeNet Health’s portfolio of Preservon®-treated allograft bio-implants include:
VG2 Cervical
VG2 Cervical – Large
VG1 Cervical VG1
Laminoplasty
ReadiGraft
MatriGraft
For more information about PRESERVON® technology, visit LifeNet Health at: http://accesslifenethealth.org/innovation/preservon/experience_preservon/
|
